Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
Laster, Andrew J, Lam, Gordon K, Gladue, Heather S, Kashif, Ahmad A, Siceloff, Erin P, Lackey, Virginia D, Robertson, Cheryl R, Toci, Ashley L, Calabrese, Leonard H
Published in Rheumatic & musculoskeletal diseases open (01.05.2022)
Published in Rheumatic & musculoskeletal diseases open (01.05.2022)
Get full text
Journal Article